Back to search
FDAFDA · Food and drugs·Recall number D-0866-2020

Desoximetasone Topical Spray, 0.25%, 2.5 mg desoximetasone, 100 mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD

Published March 11, 2020 · Recall initiated: February 19, 2020

Summary

FDA records drug Class II recall D-0866-2020, published March 11, 2020 and initiated February 19, 2020. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 876 bottles; Lot: K800475 exp. date May 2020 K800477 exp. date June 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specification; high out of specification results observed

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Product was distributed throughout the United States.
Lot
K800475 exp. date May 2020 K800477 exp. date June 2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Desoximetasone Topical Spray, 0.25%, 2.5 mg desoximetasone, 100 mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD recalled?

Yes. FDA published recall D-0866-2020 on March 11, 2020. Reported hazard: Failed Impurities/Degradation Specification; high out of specification results observed

What should I do if I have this product?

Voluntary: Firm initiated · Letter